Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis

NCT02006342 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Ketoacidosis

Interventions

DRUG: Insulin Glargine
DRUG: Regular Insulin

Sponsor

The University of Texas Health Science Center, Houston